Needham Investment Management LLC Gilead Sciences, Inc. Transaction History

Needham Investment Management LLC

$1.16 Billion
Q2 2024

A detailed history of Needham Investment Management LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Needham Investment Management LLC holds 64,000 shares of GILD stock, worth $5.64 Million. This represents 0.38% of its overall portfolio holdings.

Number of Shares

64,000

Previous 64,000 -0.0%

Holding current value

$5.64 Million

Previous $4.69 Million 6.34%

% of portfolio

0.38%

Previous 0.45%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$76.01 - $86.7 $76,010 - $86,700	-1,000 Reduced 1.54%	64,000 $4.93 Million
Q4 2022 Feb 13, 2023	SELL	$62.32 - $89.47 $560,880 - $805,230	-9,000 Reduced 12.16%	65,000 $5.58 Million
Q2 2022 Aug 12, 2022	SELL	$57.72 - $65.01 $1.5 Million - $1.69 Million	-26,000 Reduced 26.0%	74,000 $4.57 Million
Q3 2021 Nov 15, 2021	SELL	$67.69 - $73.03 $270,760 - $292,120	-4,000 Reduced 3.85%	100,000 $6.99 Million
Q2 2021 Aug 16, 2021	SELL	$63.47 - $69.35 $1.05 Million - $1.14 Million	-16,500 Reduced 13.69%	104,000 $7.16 Million
Q1 2021 May 17, 2021	SELL	$60.0 - $68.46 $450,000 - $513,449	-7,500 Reduced 5.86%	120,500 $7.79 Million
Q4 2020 Feb 16, 2021	SELL	$56.65 - $64.55 $254,925 - $290,475	-4,500 Reduced 3.4%	128,000 $7.46 Million
Q3 2020 Nov 16, 2020	SELL	$62.1 - $78.08 $527,850 - $663,680	-8,500 Reduced 6.03%	132,500 $8.37 Million
Q2 2020 Aug 14, 2020	SELL	$72.34 - $84.0 $217,020 - $252,000	-3,000 Reduced 2.08%	141,000 $10.8 Million
Q1 2020 May 15, 2020	SELL	$62.63 - $80.22 $62,630 - $80,220	-1,000 Reduced 0.69%	144,000 $10.8 Million
Q4 2018 Feb 14, 2019	SELL	$60.54 - $79.0 $121,080 - $158,000	-2,000 Reduced 1.36%	145,000 $9.07 Million
Q3 2018 Nov 14, 2018	SELL	$71.28 - $78.92 $641,520 - $710,280	-9,000 Reduced 5.77%	147,000 $11.4 Million
Q2 2018 Aug 14, 2018	SELL	$64.88 - $75.68 $64,879 - $75,680	-1,000 Reduced 0.64%	156,000 $11.1 Million
Q1 2018 May 15, 2018	SELL	$72.84 - $88.8 $291,360 - $355,200	-4,000 Reduced 2.48%	157,000 $11.8 Million
Q4 2017 Feb 14, 2018	SELL	$71.15 - $83.52 $675,925 - $793,440	-9,500 Reduced 5.57%	161,000 $11.5 Million
Q3 2017 Nov 14, 2017	SELL	$72.11 - $85.47 $288,440 - $341,880	-4,000 Reduced 2.29%	170,500 $13.8 Million
Q2 2017 Aug 14, 2017	BUY	N/A	174,500	174,500 $12.4 Million

Others Institutions Holding GILD

# of Institutions

1,893

Shares Held

1.02B

Call Options Held

12M

Put Options Held

9.04M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Needham Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Needham Investment Management LLC with notifications on news.

Account

Needham Investment Management LLC Gilead Sciences, Inc. Transaction History